Bicycle Therapeutics PLC reports results for the quarter ended in September - Earnings Summary

Bicycle Therapeutics

02/11/2023 13:26

* Bicycle Therapeutics PLC  BCYC.OQ  reported a quarterly
adjusted
loss of $1.26​​ per share for the quarter ended in September,
lower than the same quarter last year, when the company reported
EPS of -96 cents.  The mean expectation of fourteen analysts for
the quarter was for a loss of $1.17 per share. Wall Street
expected results to range from $-1.85 to -23 cents per share.
    * Revenue rose 76.1% to $5.35 million from a year ago;
analysts
expected $13.09 million. 
    * Bicycle Therapeutics PLC's reported EPS for the quarter
was a
loss of $1.26​.
    * The company reported a quarterly loss of $49.9 million.
    * Bicycle Therapeutics PLC shares had fallen by 23.6% this
quarter and lost 48.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 9.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $47.00 

This summary was machine generated from LSEG data November 2 at
01:26 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -1.17          -1.26          Missed
 Jun. 30 2023      -1.29          -1.41          Missed
 Mar. 31 2023      -1.07          -1.30          Missed
 Dec. 31 2022      -1.06          -1.01          Beat